Drug intelligence / Profile preview

ALDIPETE-T

Development stage
Approved
Lead developer
Institute Torlak
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

ALDIPETE-T is an adsorbed combination vaccine developed and manufactured by the Institute of Virology, Vaccines and Sera Torlak in Serbia. It is indicated for active immunization against pertussis (whooping cough), diphtheria, and tetanus. The vaccine formulation consists of diphtheria and tetanus toxoids along with pertussis components that are adsorbed onto an aluminum-based adjuvant to enhance the immune response. By introducing these inactivated toxins and bacterial components, the vaccine stimulates the production of protective antibodies and cellular immunity, providing long-term protection against infection and the systemic effects of the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*.

Brand names
ALDIPETE-T
Other names
pertussis, diphtheria and tetanus vaccine, adsorbed
02

Targets

TT (Tetanus toxoid)

Beyond the preview

Go deeper on ALDIPETE-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALDIPETE-T.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call